These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
3. Obesity-induced hypertension: interaction of neurohumoral and renal mechanisms. Hall JE; do Carmo JM; da Silva AA; Wang Z; Hall ME Circ Res; 2015 Mar; 116(6):991-1006. PubMed ID: 25767285 [TBL] [Abstract][Full Text] [Related]
4. Obesity-associated hypertension: new insights into mechanisms. Rahmouni K; Correia ML; Haynes WG; Mark AL Hypertension; 2005 Jan; 45(1):9-14. PubMed ID: 15583075 [TBL] [Abstract][Full Text] [Related]
5. Role of adipose tissue for cardiovascular-renal regulation in health and disease. Engeli S; Sharma AM Horm Metab Res; 2000; 32(11-12):485-99. PubMed ID: 11246814 [TBL] [Abstract][Full Text] [Related]
6. Emerging concepts in the pathophysiology and treatment of obesity-associated hypertension. Engeli S; Sharma AM Curr Opin Cardiol; 2002 Jul; 17(4):355-9. PubMed ID: 12151869 [TBL] [Abstract][Full Text] [Related]
7. Sympathetic nervous system as a target for aging and obesity-related cardiovascular diseases. Balasubramanian P; Hall D; Subramanian M Geroscience; 2019 Feb; 41(1):13-24. PubMed ID: 30519806 [TBL] [Abstract][Full Text] [Related]
8. Pathophysiology of obesity hypertension. Hall JE Curr Hypertens Rep; 2000 Apr; 2(2):139-47. PubMed ID: 10981140 [TBL] [Abstract][Full Text] [Related]
10. Hypertension in obesity. Kurukulasuriya LR; Stas S; Lastra G; Manrique C; Sowers JR Endocrinol Metab Clin North Am; 2008 Sep; 37(3):647-62, ix. PubMed ID: 18775357 [TBL] [Abstract][Full Text] [Related]
11. Obesity-related hypertension: epidemiology, pathophysiology, treatments, and the contribution of perivascular adipose tissue. Aghamohammadzadeh R; Heagerty AM Ann Med; 2012 Jun; 44 Suppl 1():S74-84. PubMed ID: 22713152 [TBL] [Abstract][Full Text] [Related]
12. Role of sympathetic nervous system and neuropeptides in obesity hypertension. Hall JE; Brands MW; Hildebrandt DA; Kuo J; Fitzgerald S Braz J Med Biol Res; 2000 Jun; 33(6):605-18. PubMed ID: 10829088 [TBL] [Abstract][Full Text] [Related]
13. Obesity hypertension. Rocchini AP Am J Hypertens; 2002 Feb; 15(2 Pt 2):50S-52S. PubMed ID: 11866230 [TBL] [Abstract][Full Text] [Related]
15. Sympathetic nervous system in obesity-related hypertension: mechanisms and clinical implications. Kalil GZ; Haynes WG Hypertens Res; 2012 Jan; 35(1):4-16. PubMed ID: 22048570 [TBL] [Abstract][Full Text] [Related]
16. Factors that influence the risk of hypertension in obese individuals. Coatmellec-Taglioni G; Ribière C Curr Opin Nephrol Hypertens; 2003 May; 12(3):305-8. PubMed ID: 12698070 [TBL] [Abstract][Full Text] [Related]
17. Mineralocorticoid receptor activation in obesity hypertension. Nagase M; Fujita T Hypertens Res; 2009 Aug; 32(8):649-57. PubMed ID: 19521418 [TBL] [Abstract][Full Text] [Related]
18. Obesity hypertension: role of leptin and sympathetic nervous system. Hall JE; Hildebrandt DA; Kuo J Am J Hypertens; 2001 Jun; 14(6 Pt 2):103S-115S. PubMed ID: 11411745 [TBL] [Abstract][Full Text] [Related]
19. The renin-angiotensin system and natriuretic peptides in obesity-associated hypertension. Engeli S; Sharma AM J Mol Med (Berl); 2001; 79(1):21-9. PubMed ID: 11327100 [TBL] [Abstract][Full Text] [Related]
20. Obesity, kidney dysfunction, and inflammation: interactions in hypertension. Hall JE; Mouton AJ; da Silva AA; Omoto ACM; Wang Z; Li X; do Carmo JM Cardiovasc Res; 2021 Jul; 117(8):1859-1876. PubMed ID: 33258945 [TBL] [Abstract][Full Text] [Related] [Next] [New Search]